tradingkey.logo
tradingkey.logo
Search

ICU Medical Inc

ICUI
Add to Watchlist
181.170USD
-1.670-0.91%
Market hours 08/24, 15:01ET
4.53BMarket Cap
96.52P/E TTM

Forecast

Currency: USD Updated: 2026-08-21
Previous score
8.86
Change
0
The current earnings forecast score of ICU Medical Inc is 8.86, ranking 11 out of 198 in the Healthcare Equipment & Supplies industry. The average price target is 180.00, with a high of 200.00 and a low of 172.00.

Analyst Rating

Based on 7 analysts
Buy
Current Rating
195.571
Target Price
+7.14%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

109
Total
7
Median
9
Average
Company name
Ratings
Analysts
ICU Medical Inc
ICUI
7
Medtronic PLC
MDT
30
Dexcom Inc
DXCM
30
Stryker Corp
SYK
30
Abbott Laboratories
ABT
29
Zimmer Biomet Holdings Inc
ZBH
29
1
2
3
...
22

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

FAQs

What is ICU Medical Inc's expected revenue for the next quarter?

ICU Medical Inc's expected revenue is 552.07M.

What is ICU Medical Inc's price target?

Analysts forecast that ICU Medical Inc's price target is USD 180.00, with the highest forecast at USD 200.00 and the lowest forecast at USD 172.00.

How have ICU Medical IncICUI's recent earnings per share performed?

The market expectation was USD 0.76, while ICU Medical IncICUI's earnings per share (EPS) for the previous quarter was USD 1.22. EPS for the next quarter is expected at USD 2.15.

What is the analyst rating for ICU Medical Inc?

Based on the ratings of ICU Medical Inc's stock from 7 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.